To identify the best evidence in the management of indicator, short and long term of prophylactic platelet transfusion in patient with myelodysplastic syndrome (MDS). We searched the latest evidence-based guidelines in PubMed,reviewed and appraised these guidelines. Clinical decision was made based on the guidelines and the actual patient with MDS. Perfect treatment effect was obtained through evidence-based clinical decision.
Citation: WANG Xiaoqin. Using Evidence-Based Guideline for Prophylactic Platelet Transfusion in Patient with Myelodysplastic Syndrome. Chinese Journal of Evidence-Based Medicine, 2005, 05(6): 482-484. doi: Copy